PECAM1 and Alzheimer disease: Immunohistochemical staining of the first two markers of the lymphatic vessels, i.e., CCL21 and CD31, showed that the two markers were significantly increased in the control AD models compared to the normal animals (p < 0.001, Figures 5(a)–5(d)).